Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $60.0800 (-1.62%) ($60.0800 - $60.0800) on Wed. Aug. 18, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.28% (three month average) | RSI | 83 | Latest Price | $60.0800(-1.62%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -1.3% a day on average for past five trading days. | Weekly Trend | EDIT advances 17.9% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(68%) IWO(63%) IWC(62%) IBUY(61%) IWM(59%) | Factors Impacting EDIT price | EDIT will decline at least -2.64% in a week (0% probabilities). VIXM(-33%) UUP(-16%) VXX(-12%) TBT(-7%) UNG(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.64% (StdDev 5.28%) | Hourly BBV | 0.1 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $61.84(-2.85%) | 10 Day Moving Average | $60.34(-0.43%) | 20 Day Moving Average | $51.58(16.48%) | To recent high | -8.1% | To recent low | 82.7% | Market Cap | $3.731b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |